Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ReNeuron gets notice of US cryptopreservation patent

ReNeuron is using cryopreservation technology in its CTX stem cell line
ReNeuron gets notice of US cryptopreservation patent
Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology

ReNeuron (LON:RENE) has received a  Notice of Allowance from the US Patent and Trademark Office for a key patent application covering its cell cryopreservation technology. 

The patent application contains broad claims relating to cryopreserved neural, retinal and mesenchymal stem cells using a formulation developed by ReNeuron that is free of toxic cryopreservants.  

ReNeuron is using cryopreservation technology in its CTX stem cell line to derive a cryopreserved, long shelf life cell therapy candidate, designated CTXcryo.

Ongoing UK clinical trials in both stroke disability and critical limb ischaemia include the technology.  

Olav Hellebø, ReNeuron’s chief executive added the company had invested heavily in patents in recent and the US Notice of Allowance for cell cryopreservation was another important addition.

PhilW.jpg
Why Invest In ReNeuron Group Plc? Read More Here

Register here to be notified of future RENE Company articles
View full RENE profile

ReNeuron Group Plc Timeline

Article
January 11 2016

Related Articles

World map made out of drugs
April 12 2016
The pharma services and drug development group has hit key milestones in the last year.
Astrazeneca-laboratory-testing_opt.jpg
October 20 2015
The highly regarded biotech entrepreneur David Evans, who is Scancell’s chairman, said given the strength of the clinical data from SCIB1 and the pipeline of potential products, further investment is warranted and in his words “could add significant value to the company”.
antibiotic.jpg
March 02 2016
In all 1,200 patients will take part in the global trials run by Motif’s partner Covance.

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.